Molecular characterization of a complex small supernumerary marker chromosome derived from chromosome 18p: an addition to the literature.

Dysmorphisms Intellectual disability Trisomy 18p a-CGH sSMC

Journal

Molecular cytogenetics
ISSN: 1755-8166
Titre abrégé: Mol Cytogenet
Pays: England
ID NLM: 101317942

Informations de publication

Date de publication:
20 Jan 2021
Historique:
received: 12 08 2020
accepted: 09 12 2020
entrez: 21 1 2021
pubmed: 22 1 2021
medline: 22 1 2021
Statut: epublish

Résumé

Small supernumerary marker chromosomes (sSMC) are a heterogeneous group of structurally abnormal chromosomes, with an incidence of 0,044% in newborns that increases up to almost 7 times in developmentally retarded patients. sSMC from all 24 chromosome have been described, most of them originate from the group of the acrocentric, with around half deriving from the chromosome 15. Non-acrocentric sSMC are less common and, in the 30 percent of the cases, are associated with phenotypic effect. Complex sSMC consist of chromosomal material derived from more than one chromosome. Genotype-phenotype correlations in patients with sSMC are difficult to assess. Clinical features depend on factors such as its size, genetic content, the involvement of imprinted genes which may be influenced by uniparental disomy and the level of mosaicism. Trisomy of the short arm of chromosome 18 (18p) is an infrequent finding and does not appear to be associated with a specific syndrome. However, mild intellectual disability with or without other anomalies is reported in almost one-third of the patients. Here we present clinical and molecular characterization of a new case of de novo complex sSMC consisting of the entire short arm of chromosome 18p associated with a centromere of either chromosome 13 or 21, evidenced in a 5-year-old boy during diagnostic workup for moderate intellectual disability and dysmorphisms. To date, only seven cases of isolated trisomy 18p due to a sSMC have been reported, three of which have been characterized by array CGH. In two of them the breakpoints and the size of the duplication have been described. In the manuscript we also reviewed cases reported in the DECIPHER database carrying similar duplication and also considered smaller duplications within the region of interest, in order to evaluate the presence of critical regions implicated in the pathological phenotype. Our case provides additional information about phenotypic effects of pure trisomy 18p, confirms chromosomal microarray analysis as gold standard to characterize complex sSMC, and supplies additional elements for genetic counselling.

Sections du résumé

BACKGROUND BACKGROUND
Small supernumerary marker chromosomes (sSMC) are a heterogeneous group of structurally abnormal chromosomes, with an incidence of 0,044% in newborns that increases up to almost 7 times in developmentally retarded patients. sSMC from all 24 chromosome have been described, most of them originate from the group of the acrocentric, with around half deriving from the chromosome 15. Non-acrocentric sSMC are less common and, in the 30 percent of the cases, are associated with phenotypic effect. Complex sSMC consist of chromosomal material derived from more than one chromosome. Genotype-phenotype correlations in patients with sSMC are difficult to assess. Clinical features depend on factors such as its size, genetic content, the involvement of imprinted genes which may be influenced by uniparental disomy and the level of mosaicism. Trisomy of the short arm of chromosome 18 (18p) is an infrequent finding and does not appear to be associated with a specific syndrome. However, mild intellectual disability with or without other anomalies is reported in almost one-third of the patients.
CASE PRESENTATION METHODS
Here we present clinical and molecular characterization of a new case of de novo complex sSMC consisting of the entire short arm of chromosome 18p associated with a centromere of either chromosome 13 or 21, evidenced in a 5-year-old boy during diagnostic workup for moderate intellectual disability and dysmorphisms. To date, only seven cases of isolated trisomy 18p due to a sSMC have been reported, three of which have been characterized by array CGH. In two of them the breakpoints and the size of the duplication have been described. In the manuscript we also reviewed cases reported in the DECIPHER database carrying similar duplication and also considered smaller duplications within the region of interest, in order to evaluate the presence of critical regions implicated in the pathological phenotype.
CONCLUSIONS CONCLUSIONS
Our case provides additional information about phenotypic effects of pure trisomy 18p, confirms chromosomal microarray analysis as gold standard to characterize complex sSMC, and supplies additional elements for genetic counselling.

Identifiants

pubmed: 33472639
doi: 10.1186/s13039-020-00519-w
pii: 10.1186/s13039-020-00519-w
pmc: PMC7818575
doi:

Types de publication

Journal Article

Langues

eng

Pagination

6

Références

Am J Hum Genet. 2009 Apr;84(4):524-33
pubmed: 19344873
Gene. 2014 Feb 15;536(1):145-50
pubmed: 24291026
Am J Med Genet A. 2007 Apr 1;143A(7):727-33
pubmed: 17330860
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16975-80
pubmed: 12475935
Genomics. 1999 May 1;57(3):429-32
pubmed: 10329010
Mol Cytogenet. 2016 Dec 3;9:89
pubmed: 27980677
Cancer Res. 2001 Mar 1;61(5):2055-61
pubmed: 11280766
Cytogenet Genome Res. 2004;107(1-2):55-67
pubmed: 15305057
Clin Dysmorphol. 2016 Jan;25(1):19-22
pubmed: 26287558
Am J Med Genet A. 2013 Jul;161A(7):1806-12
pubmed: 23695988
Cytogenet Genome Res. 2019;157(4):220-226
pubmed: 30939474
Indian Pediatr. 2010 Mar;47(3):277-9
pubmed: 20371896
Cytogenet Genome Res. 2006;112(1-2):23-34
pubmed: 16276087
Am J Med Genet. 1998 Feb 3;75(4):367-81
pubmed: 9482642
Eur J Hum Genet. 2005 Feb;13(2):154-60
pubmed: 15508017
BMC Med Genet. 2015 Jul 07;16:47
pubmed: 26149167
BMC Bioinformatics. 2018 Dec 7;19(1):470
pubmed: 30526489
Am J Med Genet A. 2013 Sep;161A(9):2363-8
pubmed: 23894094
Am J Med Genet A. 2007 Nov 15;143A(22):2727-32
pubmed: 17937429
Am J Med Genet A. 2006 Mar 1;140(5):434-41
pubmed: 16470730
Am J Hum Genet. 2014 Aug 7;95(2):227-34
pubmed: 25105227
Int J Mol Med. 2007 May;19(5):719-31
pubmed: 17390076

Auteurs

Eleonora Marchina (E)

Laboratory of Cytogenetics and Molecular Genetics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. eleonora.marchina@unibs.it.

Michela Forti (M)

Laboratory of Cytogenetics and Molecular Genetics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Mariella Tonelli (M)

Laboratory of Cytogenetics and Molecular Genetics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Stefania Maccarini (S)

Laboratory of Cytogenetics and Molecular Genetics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Francesca Malvestiti (F)

TOMA Advanced Biomedical Assay, Busto Arsizio, Varese, Italy.

Chiara Piantoni (C)

Unit of Child Neurology and Psychiatry, Civil Hospital, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Elena Filippini (E)

Unit of Child Neurology and Psychiatry, Civil Hospital, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Elisa Fazzi (E)

Unit of Child Neurology and Psychiatry, Civil Hospital, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Giuseppe Borsani (G)

Division of Biology and Genetics, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.

Classifications MeSH